Biodegradable and Sustainable Synthetic Antibodies-A Perspective

Pharmaceutics. 2023 May 9;15(5):1440. doi: 10.3390/pharmaceutics15051440.

Abstract

Molecular imprinting technology has been around for almost a century, and we have witnessed dramatic advancements in the overall design and production of molecularly imprinted polymers (MIPs), particularly in terms of possible formats of the final products when it comes to truly resembling antibody substitutes, i.e., MIP nanoparticles (MIP NPs). Nonetheless, the overall technology appears to struggle to keep up with the current global sustainability efforts, as recently elucidated in the latest comprehensive reviews, which introduced the "GREENIFICATION" concept. In this review, we will try to elucidate if these advancements in MIP nanotechnology have indeed resulted in a sustainability amelioration. We will do so by discussing the general production and purification strategies for MIP NPs, specifically from a sustainability and biodegradation perspective, also considering the final intended application and ultimate waste management.

Keywords: biodegradable polymers; molecular imprinting; molecularly imprinted polymers; nanoparticles; sustainability; sustainable imprinting; synthetic antibodies.

Publication types

  • Review

Grants and funding

This research received no external funding.